Riskpilot← Back to searchSign inGet full accessActive roles
0
directorships & management
Past roles
8
historical positions
Dissolved companies
7
in directorship history
- 2024 – 2025Chairman, Y-mAbs Therapeutics A/S
- 2019 – 2022Founder, G. Estates ApS
- 2012 – 2020Founder, Y-MABS THERAPEUTICS, ApS
- 2008 – 2014Chief Executive Officer, SG GENERICS ApS
- 2005 – 2013Management, SINGAD HOLDING ApS
- 2003 – 2014Founder, GAD INVEST ApS
- 2003 – 2013Management, SINGAD PHARMA ApS
- 1990 – 1997Board of Directors, ECU INVEST ApS
Nationality
DK
| Company | Role | Period | Ownership | Status |
|---|
| Company | Role | Period | Ownership | Status |
|---|---|---|---|---|
| ECU INVEST ApS CVR 13912238 | BoardBoard of Directors | 1990 – 1997 | — | Dissolved |
| SINGAD PHARMA ApS CVR 27252257 | ManagementManagement | 2003 – 2013 | — | Dissolved |
| GAD INVEST ApS CVR 27454658 | OtherFounder | 2003 – 2014 | — | Dissolved |
| SINGAD HOLDING ApS CVR 29150745 | ManagementManagement | 2005 – 2013 | — | Dissolved |
| SG GENERICS ApS CVR 30514076 | ManagementChief Executive Officer | 2008 – 2014 | — | Dissolved |
| Y-MABS THERAPEUTICS, ApS CVR 34879524 | OtherFounder | 2012 – 2020 | — | Dissolved |
| G. Estates ApS CVR 40338683 | OtherFounder | 2019 – 2022 | — | Dissolved |
| Y-mAbs Therapeutics A/S CVR 37053678 | BoardChairman | 2024 – 2025 | — | Active |
7 dissolved companies in directorship history
ECU INVEST ApS
CVR 13912238 · Dissolved 1997 · —
SINGAD PHARMA ApS
CVR 27252257 · Dissolved 2013 · —
GAD INVEST ApS
CVR 27454658 · Dissolved 2014 · —
SINGAD HOLDING ApS
CVR 29150745 · Dissolved 2013 · —
SG GENERICS ApS
CVR 30514076 · Dissolved 2014 · —
Y-MABS THERAPEUTICS, ApS
CVR 34879524 · Dissolved 2020 · —
G. Estates ApS
CVR 40338683 · Dissolved 2022 · —
| Person | Role | Shared companies | Profile |
|---|---|---|---|
| Board of Directors | 1company | View profile | |
| Management | 1company | View profile | |
| Board of Directors | 1company | View profile | |
| Board of Directors | 1company | View profile | |
| Management | 1company | View profile |
Thomas Gad